Soc. Generale Knock-Out SAAB/B/ DE000SY4D7K3 /
- - | Chg.- | Bid17:25:03 | Ask09:05:03 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
-EUR | - | - Bid Size: - |
- Ask Size: - |
SAAB AB ser. B | 240.4035 - | 31/12/2078 | Call |
GlobeNewswire
03/06
uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational G...
Newsfile Corp
11/04
Tor Holding and ELIE SAAB Announce Partnership for Dual Real Estate Debut in Turkey
GlobeNewswire
04/04
Schneider Electric announces global winners of second edition of its Sustainability Impact Awards
GlobeNewswire
03/04
SK hynix announces semiconductor advanced packaging investment in Purdue Research Park
GlobeNewswire
19/12/2023
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of ...
GlobeNewswire
29/11/2023
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for...
GlobeNewswire
13/11/2023
Bombardier Defense Delivers Seventh Global Aircraft for Saab’s GlobalEye Airborne Surveillance Solut...
GlobeNewswire
03/11/2023
Candel Therapeutics Announces Initial Positive Interim Data from Randomized Phase 2 Clinical Trial o...